Clinical and preclinical application of PTH and BMP to dental treatment

Abstract Bone formation is the important factor which contributes to the successful periodontal tissue regeneration in periodontitis and osseointegration of implant placement. To achieve the sufficient bone volume in the process of dental treatment, several growth factors and hormones which enhance bone formation have been evaluated in clinical and preclinical studies. BMP2 and BMP7 have recently been approved for sinus augmentation by FDA. A phase2a randomized controlled clinical studies were conducted to evaluate the potential of GDF5 to stimulate periodontal tissue regeneration and GDF5 significantly stimulated alveolar bone regeneration compared to control. Moreover, increased alveolar bone formation was observed by the use of PTH (1-34) Teriparatide in patients of severe periodontitis. PTH and GDF5 are promising agents for future periodontitis treatment.